The European Medicines Agency (EMA) has qualified MASH, the first AI tool designed to diagnose inflammatory liver disease from biopsy samples. This advancement enhances diagnostic accuracy and consistency by leveraging machine learning techniques. This innovation is crucial for healthcare systems, particularly in Europe, where liver diseases are prevalent.
🧬 EMA Qualifies First AI Tool for Liver Disease Diagnosis
